Valuation : CellaVision AB

Market Cap 377.33Cr 39Cr 34Cr 32Cr 29Cr 54Cr 3.73TCr 54Cr 145.22Cr 1.89TCr 146.62Cr 143.42Cr 6.01TCr P/E 2026 *
27.1x
P/E 2027 * 21.6x
Enterprise Value 358.58Cr 37Cr 32Cr 30Cr 27Cr 51Cr 3.55TCr 52Cr 138.01Cr 1.8TCr 139.34Cr 136.29Cr 5.72TCr EV / Sales 2026 *
4.63x
EV / Sales 2027 * 4.08x
Free-Float
81.06%
Yield 2026 *
1.74%
Yield 2027 * 1.98%
1 day+1.77%
1 week+0.25%
Current month-3.37%
1 month+3.88%
3 months+22.37%
6 months+8.06%
Current year+2.29%
1 week 157
Extreme 157
164.4
1 month 150.2
Extreme 150.2
170.4
Current year 117.6
Extreme 117.6
170.4
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
459
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Free 1,00,000 0.4193%
28/04/26 Don

Founder

76,434 0.3205%
28/04/26 Buy

Founder

20,000 0.0839%
Change 5-day change 1-year change 3-year change Capi.($)
+1.77%+0.25%-11.55%-8.32% 39Cr
+0.37%-2.53%+19.42%-31.56% 1.67TCr
+4.40%+8.97%-30.26%+60.96% 178.23Cr
+0.73%-3.74%-27.70%+23.54% 89Cr
-3.88%-12.78%-56.03%-83.72% 83Cr
-0.16%-0.27%+68.52%-3.25% 78Cr
-1.89%-2.59%-35.58%-48.27% 65Cr
-2.22%-4.26%-41.91%-46.05% 59Cr
+3.02%-15.05%-43.32%-39.78% 44Cr
-3.51%-6.87%+64.04%+45.87% 39Cr
Average -0.14%-5.09%-9.44%-13.06% 233.99Cr
Weighted average by Cap. +0.40%-4.81%+8.75%-22.64%

Financials

2026 *2027 *
Net sales 78Cr 8.02Cr 6.9Cr 6.51Cr 5.93Cr 11Cr 766.84Cr 11Cr 30Cr 388.95Cr 30Cr 29Cr 1.24TCr 87Cr 9Cr 7.74Cr 7.31Cr 6.65Cr 12Cr 860.73Cr 13Cr 33Cr 436.58Cr 34Cr 33Cr 1.39TCr
Net income 14Cr 1.44Cr 1.24Cr 1.17Cr 1.06Cr 1.99Cr 137.54Cr 2.01Cr 5.35Cr 70Cr 5.4Cr 5.28Cr 221.58Cr 17Cr 1.8Cr 1.55Cr 1.46Cr 1.33Cr 2.49Cr 172.52Cr 2.52Cr 6.71Cr 88Cr 6.78Cr 6.63Cr 277.93Cr
Net Debt -19Cr -1.94Cr -1.67Cr -1.57Cr -1.43Cr -2.68Cr -185.5Cr -2.71Cr -7.22Cr -94Cr -7.29Cr -7.13Cr -298.86Cr -22Cr -2.3Cr -1.97Cr -1.86Cr -1.7Cr -3.17Cr -219.52Cr -3.2Cr -8.54Cr -111.35Cr -8.62Cr -8.43Cr -353.67Cr
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
11/26/11 SEK 160.80 +1.64% 3,319
10/26/10 SEK 158.20 -1.74% 14,971
09/26/09 SEK 161.00 -0.74% 36,539
08/26/08 SEK 162.20 +0.12% 20,666
07/26/07 SEK 162.00 +1.00% 33,231
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
158.20SEK
Average target price
175.67SEK
Spread / Average Target
+11.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!